ArticleFrontiers in pharmacology2022

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway.

Zhen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.